51
Views
22
CrossRef citations to date
0
Altmetric
Original Article

Malignant Transformation of Monoclonal Gammopathy of Undetermined Significance: Cumulative Incidence and Prognostic Factors

, , , &
Pages 609-618 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fausto Adami, Michela Bortolin, Maurizio Lestani, Marco Chilosi & Gianpietro Semenzato. (2002) Prognostic Factors in Malignant Transformation of Monoclonal Gammopathy of Undetermined Significance. Leukemia & Lymphoma 43:8, pages 1713-1714.
Read now

Articles from other publishers (21)

Juan Manuel López Gómez, Beatriz Sacristán Enciso, María Jesús Fernández-Cavada Pollo, Virginia Bueno García & Sergio Gómez Vera. (2021) Gammapatía monoclonal de significado incierto y evolución a mieloma múltiple: Experiencia en 153 pacientes. Medicina de Familia. SEMERGEN 47:7, pages 441-447.
Crossref
Barbara J. Bain, David M. Clark & Bridget S. Wilkins. 2019. Bone Marrow Pathology. Bone Marrow Pathology 487 536 .
Mary L. McMaster, Helga M. Ögmundsdóttir, Sigurdur Y. Kristinsson & Robert A. Kyle. 2017. Waldenström’s Macroglobulinemia. Waldenström’s Macroglobulinemia 143 167 .
Stéphane Mathis, Jérôme Franques, Laurence Richard & Jean-Michel Vallat. (2016) Monoclonal gammopathy of undeterminated significance and endoneurial IgG deposition. Medicine 95:36, pages e4807.
Crossref
N. W. C. J. van de Donk, T. Mutis, P. J. Poddighe, H. M. Lokhorst & S. Zweegman. (2016) Diagnosis, risk stratification and management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. International Journal of Laboratory Hematology 38:S1, pages 110-122.
Crossref
Mohamed Hassan. (2012) Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies. World Journal of Experimental Medicine 2:2, pages 7.
Crossref
Mary L. McMaster & Ola Landgren. (2010) Prevalence, clinical aspects, and natural history of IgM MGUS. Cytometry Part B: Clinical Cytometry 78B:S1, pages S91-S97.
Crossref
Barbara J. Bain, David M. Clark & Bridget S. Wilkins. 2009. Bone Marrow Pathology. Bone Marrow Pathology 421 460 .
Jenny Bird, Judith Behrens, Jan Westin, Ingemar Turesson, Mark Drayson, Robert Beetham, Shirley D’Sa, Richard Soutar, Anders Waage, Nina Gulbrandsen, Henrik Gregersen & Eric Low. (2009) UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS). British Journal of Haematology 147:1, pages 22-42.
Crossref
Bernard Grosbois, Olivier Decaux, Lucienne Guenet, Jean Goasguen & Patrick Jego. (2009) Nosologie et prise en charge des gammapathies monoclonales. Bulletin de l'Académie Nationale de Médecine 193:5, pages 1069-1087.
Crossref
Cees G. Schaar, Saskia le Cessie, Simone Snijder, Paul F. H. Franck, Pierre W. Wijermans, Cisca Ong & Hanneke Kluin-Nelemans. (2009) Long-term follow-up of a population based cohort with monoclonal proteinaemia. British Journal of Haematology 144:2, pages 176-184.
Crossref
Olivier Decaux, Hervé Avet-Loiseau & Bernard Grosbois. (2007) Transformation maligne des gammapathies monoclonales de signification indéterminée. La Presse Médicale 36:12, pages 1985-1996.
Crossref
Dominik D. Alexander, Pamela J. Mink, Hans-Olov Adami, Philip Cole, Jack S. Mandel, Martin M. Oken & Dimitrios Trichopoulos. (2007) Multiple myeloma: A review of the epidemiologic literature. International Journal of Cancer 120:S12, pages 40-61.
Crossref
Olivier Decaux, Marc Cuggia, Annie Ruelland, Claire Cazalets, Bérangère Cador, Patrick Jego & Bernard Grosbois. (2006) Suivi évolutif des gammapathies monoclonales de signification indéterminée. La Presse Médicale 35:7-8, pages 1143-1150.
Crossref
Robert A. Kyle & S. Vincent Rajkumar. (2005) Monoclonal Gammopathy of Undetermined Significance. Clinical Lymphoma and Myeloma 6:2, pages 102-114.
Crossref
Makiko Kagaya & Hiroyuki Takahashi. (2005) A Case of Type I Cryoglobulinemia Associated with a Monoclonal Gammopathy of Undetermined Significance (MGUS). The Journal of Dermatology 32:2, pages 128-131.
Crossref
Enrique Bergón, Elena Miravalles, Elena Bergón, Isabel Miranda & Marta Bergón. (2005) The predictive power of serum κ/λ ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma. Clinical Chemistry and Laboratory Medicine (CCLM) 43:1.
Crossref
Robert A. Kyle. 2004. Biology and Management of Multiple Myeloma. Biology and Management of Multiple Myeloma 93 126 .
Robert A. Kyle & S. Vincent Rajkumar. (2003) Monoclonal gammopathies of undetermined significance: a review. Immunological Reviews 194:1, pages 112-139.
Crossref
S. Montoto, M. Rozman, L. Rosiñol, E. Nadal, E. Giné, M. Aymerich, A. Ferrer, J. Esteve, F. Bosch, A. López-Guillermo, J. Bladé & E. Montserrat. (2003) Malignant transformation in IgM monoclonal gammopathy of undetermined significance. Seminars in Oncology 30:2, pages 178-181.
Crossref
O. Decaux, C. Cazalets-Lacoste, B. Cador-Rousseau, E. Laurat, M. Sebillot, J. Bracq, P. Jego, R. Leblay & B. Grosbois. (2002) Gammapathie monoclonale de signification indéterminée : suivi évolutif de 51 patients âgés de plus de 70 ans. La Revue de Médecine Interne 23:9, pages 751-758.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.